Comprehensive analysis of Syk gene methylation in colorectal cancer. Issue 3 (12th May 2021)

• Record Type: Journal Article
• Authors: Bu, Fanqin; Zhu, Xiaojian; Liu, Sicheng; Lin, Kang; Zhu, Jinfeng; Huang, Jun
• Is Part Of: Immunity, inflammation and disease. Volume 9:Issue 3(2021)
• Page Start: 923
• Page End: 931
• Publication Date: 2021-05-12
• Subjects: c‐Myc -- colorectal cancer -- metastasis -- Syk; Immunology -- Periodicals; Immunity -- Periodicals; Inflammation -- Periodicals; 616.079
• DOI: 10.1002/iid3.449
• Languages: English
• ISSNs: 2050-4527

Abstract

Abstract: Background : Metastasis of colorectal cancer (CRC) extremely affects the prognosis of CRC patients. Recently, the genetic methylation has been shown to associate with tumor metastasis. This research aimed to explore the Syk gene, which is frequently hypermethylated in different cancers, and its impact on the metastasis of CRC cells. Methods : We employed the UALCAN database for the detection of the methylation levels of Syk in different cancers. CIBERSORT, TIMER and TISIDB tools were employed to analyze the association of Syk expression with immune features of CRC. Treatment with decitabine has been noted to restore the expression of Syk in CRC cells. The invasion and migration abilities of CRC cell lines were determined using transwell and wound healing assays. The correlation between Syk and c‐Myc was established using the GEPIA2 database and Western blot assays. ​Results : Our results, based on UALCAN, revealed that the methylation level of Syk was altered in diverse cancers including colon adenocarcinoma. We found that expression profile and methylation level of Syk was correlated with immune features of colon adenocarcinoma. Decitabine can restore the expression of Syk in HCT116 and SW480 cells, hence affecting their migration and invasion. Results from GEPIA2 showed that Syk expression was correlated with c‐Myc, while Western blotting analysis revealed a negative association between the expression level of Syk and c‐Myc. ​Conclusions :​ ​This study demonstrates that the expression of Syk could be restored by decitabine in colorectal cancer, thus affecting the migration and invasion abilities of CRC cells. Abstract : In our study, we aimed to research the correlation of methylation level of Syk and metastasis of colorectal cancer (CRC). We further used Decitabine to restore the expression of Syk in CRC cells. The results revealed that Decitabine could restore the expression of Syk and therefore prohibited the migration and invasion of CRC cells.